After lung cancer treatment ends, scans do not stop. Regular imaging continues for years because the time after treatment carries real risk of cancer coming back or of a second new tumor. This article covers the recommended imaging schedule after treatment, what common scan findings mean, and how to manage worry while waiting for results.
Why Surveillance Continues After Treatment
Lung cancer treatment – whether surgery, radiation, chemotherapy, or a combination – aims to remove or destroy all detectable cancer. But it does not guarantee that every cancer cell is gone. Some cells may stay dormant and regrow months or years later. This is called recurrence. A 2023 review in BMC Cancer found that recurrence occurs in up to 30% of patients after surgery meant to cure their lung cancer. A separate risk is a second primary lung cancer – a brand new tumor in someone who has had lung cancer before.
Finding either one early, while still small and localized, may mean more treatment choices. That’s why surveillance imaging is part of standard care long after active treatment ends. To learn about the molecular markers that guide initial treatment and sometimes affect surveillance planning, see Lung Cancer Biomarkers: What Every New Patient Should Know.
What the ASCO Guideline Recommends
The American Society of Clinical Oncology (ASCO) published a lung cancer surveillance guideline in early 2020, covering stage I through III non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) after curative-intent therapy. The full guideline can be found at PubMed (PMID 31829901). The recommended imaging schedule is:
- Chest CT scan every 6 months for the first 2 years after treatment ends
- Low-dose chest CT scan once per year from year 3 onward
After the first 2 years, the focus shifts. Early surveillance targets recurrence of the original cancer. Starting in year 3, annual scans focus more on finding a second primary lung cancer. That’s why low-dose CT, the same type used to screen high-risk people for lung cancer, is used from year 3 forward. The guideline also says what should NOT be part of routine surveillance:
- FDG-PET/CT imaging – not recommended as a routine follow-up tool for all patients
- Circulating biomarkers or blood-based tumor markers – not recommended as a substitute for CT imaging
The guideline also says that age alone should not keep patients out of surveillance. If a patient is able and willing to accept more treatment if something shows up, surveillance is right for them no matter their age.
How Scan Frequency Works in Practice
Some centers follow slightly different timing but stay within the same basic framework. An NCBI systematic analysis on imaging after lung cancer surgery found that some institutions schedule scans at months 3, 6, 12, 18, and 24, then annually after that. Others use a simpler every-6-months then yearly cycle. These differences reflect local practices and how individual patients’ risks change, not departures from the guideline’s intent. If your schedule doesn’t seem to match your stage and treatment type, ask your oncologist to explain it at your next visit. It is a reasonable question at any follow-up appointment.
What Scans Are Looking For
Each surveillance CT compares your current lung images against every prior scan in your record. The radiologist looks at the size and appearance of old nodules or scars, any new spots or masses, changes in lymph nodes nearby, and fluid or other changes in the chest.
Scan reports use technical language. Phrases like ‘stable,’ ‘unchanged,’ and ‘no evidence of new disease’ are generally favorable. Phrases like ‘new nodule,’ ‘larger than before,’ or ‘unclear finding’ mean more testing is needed, but they don’t prove cancer came back. Your oncologist – not the radiology report alone – is the right source for interpreting what any finding means for you specifically.
Understanding Nodule Findings
Nodules on post-treatment scans are common and frequently benign. Scar tissue from surgery or radiation, healed infections, and inflammatory changes can all appear as nodules on CT images. Radiologists consider several features when deciding how to respond:
- Is the nodule new, or was it visible on a previous scan?
- Has it grown, stayed the same, or become smaller since the last imaging?
- Is it solid, ground-glass in appearance (hazy), or part-solid?
- What is its size and where in the lung is it located?
A small nodule that stays the same size on two or three scans in a row is usually watched with more imaging rather than biopsied right away. A nodule that is new or bigger usually means action. This might be a repeat CT in 2 to 3 months, a PET scan to check how active it is, or a biopsy. The NCBI analysis above found that regular CT follow-up caught more early recurrences and second cancers than doing less scanning, and some early-caught cancers could still be cured. That’s why consistent follow-up matters, even when scan after scan comes back clear.
Scanxiety: The Worry That Comes With Surveillance
The worry that builds before imaging and while waiting for results is so common it has its own clinical name: scanxiety. A 2023 study followed NSCLC patients and found that scanxiety was linked to lower emotional well-being and lower quality of life. The worry usually peaked in the days before a scan and stayed high while waiting for results.
A 2024 review in Frontiers in Oncology, available at PubMed Central, said roughly half of cancer survivors have clinically high fear of cancer coming back. In early-stage NSCLC, younger patients at diagnosis, higher starting stage, and less time since treatment all linked to higher fear. Fear of recurrence is not a sign of poor mental health. It’s a normal, expected response when a future scan really could bring bad news. If you’re managing long-term scan worry, see Non-Hodgkin Lymphoma and Scanxiety: Managing Surveillance Anxiety and Rebuilding Confidence After Treatment – it covers coping strategies that work for any cancer.
Approaches That May Help Manage Scan Worry
Different approaches help with fear of recurrence. Several strategies have helped cancer survivors manage this worry:
- Recognize the scan cycle. For most people, worry peaks in the days before a scan and while waiting for results. Knowing this pattern helps you plan ahead – schedule easier activities and more time with people you care about on those days, so you’re ready.
- Cognitive behavioral therapy (CBT). CBT works by finding and changing unhelpful thought patterns. ConquerFear, a CBT program tested in randomized trials, was made for cancer survivors with high fear of recurrence and reduced fear of progression in people who completed it.
- Mind-body practices. Breathing exercises, guided relaxation, and mindfulness have been studied in cancer survivors. A 2024 review found that online mind-body programs for fear of recurrence were doable and helped reduce fear scores.
- Ask for specific information. Some people feel calmer when they know their actual recurrence risk based on stage, pathology, and scan history, rather than just hearing general reassurance. Others prefer not to hear statistics. Let your oncologist know which approach helps you feel more in control.
- Peer support. Lung cancer support groups, including online groups from the American Lung Association, can ease the loneliness that scan worry creates. Social support is linked to better mental health in cancer survivors and works with, not instead of, medical care.
Practical Steps for Each Scan Appointment
Having a plan for scan days helps you feel less powerless:
- Confirm the scan type in advance. Ask whether the appointment is a contrast CT, low-dose CT, or another imaging type. Some contrast scans require fasting or specific hydration beforehand.
- Write down your questions before the visit. Useful ones: Is my scan schedule consistent with current guidelines for my stage? What would a new finding mean for my next steps? How soon will I receive results, and who will contact me?
- Plan for the waiting time. Results usually come back in 1 to 3 days. Schedule things you enjoy during that time instead of waiting by the phone all day.
- Ask what symptoms mean you should call early. Your oncologist can tell you what counts as a warning sign – like a new cough that won’t go away, unexplained weight loss, new bone pain, or unusual shortness of breath – when you should call before your next scan.
- Go to every scheduled scan. Scan worry can make you want to put it off, but going to each one matters for finding problems early. Research shows that people who stick to their scan schedule do better.
Integrative Support During the Surveillance Phase
Some people after treatment look into integrative approaches to feel better – like supplements, stress-reducing compounds, or herbal products studied in cancer care. If you’re thinking about this, talk to your oncologist first. Some supplements interact with medicines you might still be taking or can change lab values your team watches. To see what’s available and how products are made, you can browse Oncostore’s integrative oncology products. They include options studied in cancer care with clear information about dose and sourcing.
Talk to a doctor before adding any supplement or herbal product if you take prescription medicine, are pregnant, or are breastfeeding.
This article is for general information only, not medical advice. Always talk to your oncologist or care team about your specific situation.
